The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker)

Overview of attention for article published in Cardiovascular Diabetology, February 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 65 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure

Cited by Canadian Agency for Drugs and Technologies in Health on 20 Sep 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.